Nadeem Bilani

720 total citations · 1 hit paper
38 papers, 364 citations indexed

About

Nadeem Bilani is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nadeem Bilani has authored 38 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 15 papers in Cancer Research and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nadeem Bilani's work include Breast Cancer Treatment Studies (11 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Economic and Financial Impacts of Cancer (4 papers). Nadeem Bilani is often cited by papers focused on Breast Cancer Treatment Studies (11 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Economic and Financial Impacts of Cancer (4 papers). Nadeem Bilani collaborates with scholars based in United States, Lebanon and Canada. Nadeem Bilani's co-authors include Zeina Nahleh, Leah Elson, Elizabeth Blessing Elimimian, Marita Yaghi, Sabine Allam, Rola Jaafar, Hong Liang, Morgan Bou Zerdan, Maroun Bou Zerdan and Hisham F. Bahmad and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Frontiers in Pharmacology.

In The Last Decade

Nadeem Bilani

34 papers receiving 360 citations

Hit Papers

Triple Negative Breast Cancer: Updates on Classification ... 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nadeem Bilani United States 10 161 105 82 74 35 38 364
Sasha Lupichuk Canada 10 157 1.0× 79 0.8× 86 1.0× 64 0.9× 25 0.7× 29 328
Daniel Murphy United States 4 177 1.1× 106 1.0× 126 1.5× 92 1.2× 38 1.1× 9 450
Andrea Li Ann Wong Singapore 12 161 1.0× 73 0.7× 137 1.7× 47 0.6× 23 0.7× 45 418
Stella Winters United States 3 179 1.1× 106 1.0× 125 1.5× 47 0.6× 38 1.1× 6 386
Melanie Seal Canada 9 202 1.3× 135 1.3× 132 1.6× 96 1.3× 48 1.4× 25 447
Agnieszka Kolak Poland 6 110 0.7× 93 0.9× 109 1.3× 49 0.7× 24 0.7× 12 382
Muhammad Tahir Canada 10 124 0.8× 137 1.3× 175 2.1× 57 0.8× 25 0.7× 25 451
Charmaine Martin United States 4 185 1.1× 106 1.0× 125 1.5× 47 0.6× 38 1.1× 6 412
Т. Yu. Semiglazova Russia 7 237 1.5× 71 0.7× 57 0.7× 79 1.1× 24 0.7× 140 367

Countries citing papers authored by Nadeem Bilani

Since Specialization
Citations

This map shows the geographic impact of Nadeem Bilani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadeem Bilani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadeem Bilani more than expected).

Fields of papers citing papers by Nadeem Bilani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadeem Bilani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadeem Bilani. The network helps show where Nadeem Bilani may publish in the future.

Co-authorship network of co-authors of Nadeem Bilani

This figure shows the co-authorship network connecting the top 25 collaborators of Nadeem Bilani. A scholar is included among the top collaborators of Nadeem Bilani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadeem Bilani. Nadeem Bilani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bilani, Nadeem, et al.. (2024). Origin associated with heterogeneity amongst Hispanic patients with breast cancer in the United States.. Journal of Clinical Oncology. 42(16_suppl). e23077–e23077.
2.
Sheng, Tianxiang, Mollie Hobensack, Nadeem Bilani, et al.. (2024). Patient factors associated with early vs late referral to supportive oncology.. JCO Oncology Practice. 20(10_suppl). 202–202. 1 indexed citations
3.
Bilani, Nadeem, et al.. (2023). Geographic Origin may Affect Outcomes for Hispanic Patients with Non-Small Cell Lung Cancer in the United States. Clinical Lung Cancer. 24(6). e219–e225. 1 indexed citations
4.
Bilani, Nadeem, Marita Yaghi, Leah Elson, et al.. (2022). Factors Associated With the Decision to Decline Chemotherapy in Patients With Early-stage, ER+/HER2- Breast Cancer and High-risk Scoring on Genomic Assays. Clinical Breast Cancer. 22(4). 367–373. 2 indexed citations
5.
Bilani, Nadeem, et al.. (2022). Does the 21-gene recurrence score have clinical utility in HR+/HER2+ breast cancer?. The Breast. 66. 49–53. 1 indexed citations
6.
Yaghi, Marita, et al.. (2022). Management of HR+/HER2+ lobular breast cancer and trends do not mirror better outcomes. The Breast. 64. 112–120. 2 indexed citations
7.
Yaghi, Marita, et al.. (2022). Efficacy of chemotherapy in patients with HR+/HER2–Invasive lobular breast cancer. Cancer Treatment and Research Communications. 34. 100666–100666. 1 indexed citations
8.
Bilani, Nadeem, et al.. (2021). Metastasectomy versus radiation of secondary sites in stage IV breast cancer: Analysis from a national cancer registry. The Breast. 60. 185–191. 4 indexed citations
9.
Bilani, Nadeem, et al.. (2021). Newly-identified Pathways Relating Vitamin D to Carcinogenesis: A Review. In Vivo. 35(3). 1345–1354. 10 indexed citations
10.
Bilani, Nadeem, et al.. (2021). Effect of immunotherapy on overall survival in limited-stage small cell lung carcinoma: a national cancer database analysis. Therapeutic Advances in Medical Oncology. 13. 7 indexed citations
11.
Bilani, Nadeem, Marita Yaghi, Leah Elson, et al.. (2021). Survival benefit of a combined surgical approach in patients with metastatic breast cancer. Journal of Surgical Oncology. 124(8). 1235–1241. 7 indexed citations
12.
Elimimian, Elizabeth Blessing, Thomas A. Samuel, Hong Liang, et al.. (2021). Clinical and Demographic Factors, Treatment Patterns, and Overall Survival Associated With Rare Triple-Negative Breast Carcinomas in the US. JAMA Network Open. 4(4). e214123–e214123. 25 indexed citations
13.
Elimimian, Elizabeth Blessing, et al.. (2021). Histologic Transformation in an Untreated Waldenstrom’s Macroglobulinemia After 14 Years: Case Report and Review of the Literature. Journal of Hematology. 10(1). 25–29. 1 indexed citations
14.
Bilani, Nadeem, Leah Elson, Felipe Martinez, et al.. (2020). A Multimodal Approach to Evaluate for Cardiac Metastasis in a Case of Non-Small Cell Lung Cancer. Case Reports in Oncology. 13(1). 212–218. 1 indexed citations
15.
Bilani, Nadeem, Leah Elson, Hong Liang, Elizabeth Blessing Elimimian, & Zeina Nahleh. (2020). Effect of Surgery at Primary and Metastatic Sites in Patients With Stage IV Breast Cancer. Clinical Breast Cancer. 21(3). 170–180. 14 indexed citations
16.
Elimimian, Elizabeth Blessing, Leah Elson, Hong Liang, et al.. (2020). Male Breast Cancer: A Comparative Analysis from the National Cancer Database. The World Journal of Men s Health. 39(3). 506–506. 21 indexed citations
17.
Chaulagain, Chakra P., et al.. (2020). How We Manage Systemic Immunoglobulin Heavy Chain Amyloidosis (AH Amyloidosis) and Immunoglobulin Heavy-and-Light-Chain Amyloidosis (AH/AL Amyloidosis). Clinical Lymphoma Myeloma & Leukemia. 20(11). e826–e831. 5 indexed citations
18.
Bilani, Nadeem, et al.. (2019). Illness cognition and health anxiety in parents of children with cancer. Journal of Psychosocial Oncology. 37(6). 713–728. 18 indexed citations
19.
Bilani, Nadeem, Michael Dagher, & Nathalie K. Zgheib. (2017). Precision Genetic and Genomic Medicine in the Middle East and North Africa Region: Are We There Yet?. Public Health Genomics. 20(3). 149–157. 9 indexed citations
20.
Bilani, Nadeem, Hisham F. Bahmad, & Wassim Abou‐Kheir. (2017). Prostate Cancer and Aspirin Use: Synopsis of the Proposed Molecular Mechanisms. Frontiers in Pharmacology. 8. 145–145. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026